Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Multiple myeloma analysis from ASH 2017

Dr Maxim Solovev and Dr Sung-Soo Yoon
Multiple myeloma analysis from ASH 2017 ( Dr Maxim Solovev and Dr Sung-Soo Yoon )
12 Dec 2017

Multiple myeloma highlights from ASH 2017

Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey
Multiple myeloma highlights from ASH 2017 ( Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey )
12 Dec 2017

ASH 2017: Immunotherapy for multiple myeloma

Prof Paul Richardson & Dr Wenming Chen
ASH 2017: Immunotherapy for multiple myeloma ( Prof Paul Richardson &  Dr Wenming Chen )
12 Dec 2017

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma

Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
11 Dec 2017

REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies

Dr Max Topp - University of Wurzburg, Wurzburg, Germany
REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies ( Dr Max Topp - University of Wurzburg, Wurzburg, Germany )
11 Dec 2017

T cell therapy for ALL

Dr Max Topp - University of Wurzburg, Wurzburg, Germany
T cell therapy for ALL ( Dr Max Topp - University of Wurzburg, Wurzburg, Germany )
11 Dec 2017

Immunosuppressive therapy in myelodysplastic syndrome

Dr Maximilian Stahl - Yale Cancer Center, New Haven, USA
Immunosuppressive therapy in myelodysplastic syndrome ( Dr Maximilian Stahl - Yale Cancer Center, New Haven, USA )
11 Dec 2017

The ACE-LY-004 study of acalabrutinib monotherapy for mantle cell lymphoma

Dr Michael Wang - MD Anderson Cancer Center, Houston, USA
The ACE-LY-004 study of acalabrutinib monotherapy for mantle cell lymphoma ( Dr Michael Wang - MD Anderson Cancer Center, Houston, USA )
11 Dec 2017

Why we are not ready for personalised medicine

Prof Tito Fojo - Columbia University, New York, USA
Why we are not ready for personalised medicine ( Prof Tito Fojo - Columbia University, New York, USA )
11 Dec 2017

Genetically profiling entire populations, starting with Estonia

Dr Tonu Esko - Estonian Biobank, Estonian Genome Center, University of Tartu, Tartu, Estonia
Genetically profiling entire populations, starting with Estonia ( Dr Tonu Esko -  Estonian Biobank, Estonian Genome Center, University of Tartu, Tartu, Estonia )
11 Dec 2017

Hypomethylating agents for relapsed and refractory acute myeloid leukaemia

Dr Maximilian Stahl - Yale Cancer Center, New Haven, USA
Hypomethylating agents for relapsed and refractory acute myeloid leukaemia ( Dr Maximilian Stahl - Yale Cancer Center, New Haven, USA )
11 Dec 2017

How does ancestry affect your health?

Dr Eimear Kenny - Icahn School of Medicine at Mount Sinai, New York, USA
How does ancestry affect your health? ( Dr Eimear Kenny -  Icahn School of Medicine at Mount Sinai, New York, USA )
11 Dec 2017